Suzhou Fushilai Pharmaceutical Co. Ltd. (301258) — Cash Flow Quality Index
Suzhou Fushilai Pharmaceutical Co. Ltd. (301258) has a Cash Flow Quality Index of 2.87x as of December 2024. Operating cash flow of CN¥47.07 Million exceeds net income of CN¥16.41 Million, indicating high earnings quality where cash backs reported profits. Also explore 301258 current and non-current assets for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Suzhou Fushilai Pharmaceutical Co. Ltd. Cash Flow Quality Index (2019–2024)
Historical Cash Flow Quality Index for Suzhou Fushilai Pharmaceutical Co. Ltd. across 6 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 301258 tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Suzhou Fushilai Pharmaceutical Co. Ltd. (2019–2024)
Year-by-year earnings quality comparison for Suzhou Fushilai Pharmaceutical Co. Ltd.. For live market cap and the full company financial profile, see 301258 company net worth.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 2.87x | CN¥47.07 Million | CN¥16.41 Million | ▲ +239.6% |
| 2023 | 0.84x | CN¥94.77 Million | CN¥112.18 Million | ▼ -0.9% |
| 2022 | 0.85x | CN¥151.19 Million | CN¥177.30 Million | ▼ -48.7% |
| 2021 | 1.66x | CN¥199.73 Million | CN¥120.20 Million | ▲ +40.5% |
| 2020 | 1.18x | CN¥166.85 Million | CN¥141.05 Million | ▲ +14.5% |
| 2019 | 1.03x | CN¥150.55 Million | CN¥145.71 Million | — |